Navigation Links
Kessler Foundation scientists confirm effectiveness of cognitive rehabilitation in MS
Date:8/8/2014

WEST ORANGE, NJ August 8, 2014. Kessler Foundation researchers published long-term followup results of their MEMREHAB trial, which show that in individuals with MS, patterns of brain activity associated with learning were maintained at 6 months post training. The article, A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial, was published online ahead of print on June 14 by Brain Imaging and Behavior (doi: 10.1007/s11682-014-9309-9). The article appeared in the Neuroimaging and Rehabilitation Special Issue. The authors are Ekaterina Dobryakova, PhD, Glenn Wylie, DPhil, John DeLuca, PhD, and Nancy Chiaravalloti, PhD, of Kessler Foundation.

This pilot study was based on the Foundation's MEMREHAB Trial, which provided the first Class I evidence for the efficacy of cognitive rehabilitation in MS. (Chiaravalloti N, et al: An RCT to treat learning impairment in MS. Neurology 2013(81) doi: 10.1212/01.wnl.0000437295.97946.a8S), was released as an epub ahead of print on November 8. The 10-session memory retraining protocol used in the MEMREHAB study was the modified Story Memory Technique (mSMT).

For the pilot study, participants underwent evaluation of memory performance and brain activity at baseline, immediately following memory retraining, and at 6-month followup. Results showed that the patterns of increased cerebral activation that correlated with learning were maintained at 6-month followup. "These results support the long-term effectiveness of cognitive rehabilitation in individuals with cognitive impairment caused by MS," said Nancy Chiaravalloti, PhD, director of Neuroscience & Neuropsychology and Traumatic Brain Injury (TBI) Research at Kessler Foundation."For optimal care, it is crucial for clinicians who care for this population to become familiar with the mSMT protocol."

The mSMT protocol has been translated into Spanish and is being used in the U.S., Mexico, and Argentina. A Chinese translation has also been completed for use in upcoming studies. The protocol is currently being tested in the population with cognitive impairment caused by TBI.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. Kessler funded as satellite site for NIH Stroke Trials Network
2. Dr. Dobryakova of Kessler Foundation receives New Jersey Neuropsychological Society award
3. Kessler Foundation expert authors article on social enterprise business models
4. Kessler Foundation scientist named 63rd Mendel Lecturer by St. Peters University
5. Kessler Foundation scientists receive Biogen Idec grant to study actual reality in MS
6. Kessler Foundation receives MS Research Center Award from National MS Society
7. Kessler Foundation MS scientist awarded Patterson Trust Award in Clinical Research
8. Kessler Foundation MS researchers study predictors of employment status
9. Kessler Foundation to improve home care for spinal cord injury with Department of Defense grant
10. Kessler Foundation awarded grant to study self-generated learning in multiple sclerosis
11. Kessler Foundation collaborates with UNH on NIDRR Rehabilitation Research and Training Center grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 2016 , ... Center for Autism and Related Disorders (CARD) Portland today announced ... disorder (ASD) and other developmental disabilities. The group, which is being launched with the ... the opportunity to share stories and advice, seek help, and continue their education on ...
(Date:12/2/2016)... ... 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the cover of ... was inspired to practice medicine at an early age by his father, who was ... diagnoses and prescribing medicine,” he states. “It is about building relationships with people; relationships ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens report losing ... report speaking with their child about sex related topics, less than 60 percent spoke ... proud to announce the launch of its second edition of the “Sexual Wellness” campaign, ...
(Date:12/2/2016)... ... 02, 2016 , ... CloudLIMS.com, a class-leading provider of Laboratory ... CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of their ... version is a faster and a more efficient product, allowing batch processing of ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... -- UCB is pleased to announce that 12 scientific abstracts have ... American Epilepsy Society (AES) Annual Meeting, which takes place ... USA. 1-12 Data being presented include ... ® (lacosamide) CV and BRIVIACT ® (brivaracetam) CV. ... state of the union of epilepsy care and antiepileptic drugs ...
(Date:12/2/2016)... -- Allergan plc (NYSE: AGN ), a leading ... announced Accelerated Share Repurchase (ASR) Program. Logo - ... , ... announced, the Company entered into a variable tenor ASR arrangement ... $10 billion of its ordinary shares. Approximately 40.5 million shares ...
(Date:11/30/2016)... , Nov 30, 2016 Research and ... Intracranial Pressure Monitoring Devices 2017 - MedCore" report to their offering. ... , , ... brain and the skull. In healthy individuals, it is circulated though the ... are cases where the amount of CSF surrounding the brain changes significantly. ...
Breaking Medicine Technology: